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Distribution of coronary artery risk factors: a regional analysis
Mehmet BOSTAN1, Ömer ŞATIROĞLU1, Hüseyin Avni UYDU2, Yüksel ÇİÇEK1, Aytun ÇANGA3,
Zakir KARADAĞ3, Ahmet TEMİZ3, Yavuz UĞURLU3, Mehtap ATAK2, Engin BOZKURT1

Aim: To analyze the frequency and distribution of coronary artery risk factors in the city of Rize and its surrounding
areas.
Materials and methods: This observational study included 452 patients (333 men, 119 women). In addition to
demographic characteristics of the patients, conventional risk factors were also recorded. The patients were grouped
according to their ages, gender, and electrocardiographic characteristics.
Results: The mean age of participants was 63 ± 13 years and 74% were male. Smoking and hypertension (HT) were seen
more often (71%) in younger male patients. No difference among age groups was detected with regard to the occurrence
of diabetes mellitus. The levels of HDL-cholesterol (P < 0.001) and the ratio of total cholesterol to HDL-cholesterol (P
< 0.05) were found to be relatively higher in female patients. The prevalence of smoking and familial risk factors both
decreased with age.
Conclusion: At least one of these risk factors was detected in 97% of patients. Therefore, our study continues to
emphasize the crucial role of modification of risk factors in patients with coronary artery disease, the most important
etiologic factor for morbidity and mortality.
Key words: Coronary artery disease, risk factors, regional

Koroner arter hastalığı risk faktörlerinin dağılımı: Bölgesel bir analiz
Amaç: Bu çalışmadaki amacımız, Rize ili ve civarında koroner arter risk faktörlerinin sıklık ve dağılımını incelemektir.
Yöntem ve gereç: Bu gözlemsel çalışmaya, 452 hasta (333 erkek, 119 kadın) alındı. Hastaların demografik özelliklerinin
yanı sıra, geleneksel risk faktörleri kaydedildi. Hastalar yaşa, cinsiyete ve elektrokardiyografik özelliklerine göre gruplara
ayrıldı.
Bulgular: Çalışmaya katılan hastaların yaş ortalaması 63 ± 13 iken, % 74’ü erkekti. Sigara kullanımı ve HT genç yaşta
ve erkeklerde daha fazla görüldü (% 71). Diyabetes mellitusta yaş grupları arasında fark tespit edilmedi. Kadınlarda
HDL-C (P < 0,001) ve Total-C/HDL-C oranı (P < 0,05) erkeklere göre daha yüksek bulundu. Sigara kullanımı ve aile
hikayesi yaşla birlikte azalma gösterdi.
Sonuç: Hastaların % 97’sinde en az bir risk faktörü mevcuttu. Dolayısıyla çalışmamız, en önemli morbidite ve mortalite
nedeni olan koroner arter hastalığında, hastalardaki risk faktör değişikliğinin ne kadar önemli olduğunu bizlere tekrar
vurgulamaktadır.
Anahtar sözcükler: Koroner arter hastalığı, risk faktörleri, bölgesel
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Introduction
Coronary artery diseases (CAD) are the most
important causes of morbidity and mortality in
developed and developing countries (1). Since
countries differ in terms of cardiovascular risk
factors, regional differences in the same population
can be also observed (2,3).
Developments in the management of important
modifiable risk factors such as dyslipidemia,
hypertension (HT), smoking, and diabetes mellitus
(DM) have significantly reduced the possibility of
new coronary events (both fatal and non-fatal), and
have improved the likelihood of survival. In studies
performed, cases of atherosclerotic vascular diseases
involving both coronary and non-coronary arteries
demonstrated the utmost benefit from secondary
prophylaxis (4-7).
In the management of CAD, modification of risk
factors is and will continue to be an indispensable
part of the treatment strategy, despite pertinent
technological advances in cardiovascular therapeutics
(8).
In our country, the distribution of cardiovascular
risk factors has been analyzed using a randomized
sampling method in the TEKHARF study. In this
study, the frequency of CAD was found to be 5.8%
in male and 5% in female subjects (9). Despite
this availability of nationwide data concerning the
frequency of CAD, adequate relevant data related to
specific regions are lacking.
The purpose of this study was to determine the
distribution of coronary risk factors among hospital
cases diagnosed as acute coronary syndrome in
our center. Furthermore, we have investigated their
distribution according to age groups, gender, and
subtypes of acute coronary syndrome, in order to
finally update data about our geographic region.
Materials and methods
Patients suffering from acute coronary syndrome
between January 2009-2010 were enrolled in the
study. The diagnosis was made on the basis of medical
history, electrocardiographic (ECG) findings, and
cardiac enzyme levels. The patients were classified
according to gender, age groups [young: ≤44 years
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(Group 1), middle aged: 45-64 years (Group 2),
and advanced age: ≥65 years (Group 3)], and ECG
findings [patients with ST elevation (Group 1), ST
depression (Group 2), and without any change in
ECG (Group 3)].
All patients were examined by an experienced
cardiologist immediately after hospitalization.
Information obtained pertaining to family history,
the presence of DM, HT, smoking, body mass index
(BMI), and other demographic characteristics was
recorded. Patients with a history of HT, those using
antihypertensive drugs, and those with blood pressure
above 140/90 mmHg on recurrent measurements
were defined as hypertensive cases. Those with a
history of DM, and/or hyperglycemia (as defined
according to the World Health Organization (WHO)
criteria) were accepted as cases with DM. Patients
with at least one first degree relative having a history
of CAD at an early age (<55 years for males, and <65
years for females) or sudden cardiac death (SCD) were
considered as potential candidates for CAD. Patients
who were using tobacco products upon referral to
our hospital and those that had quit smoking within
the previous year were considered smokers.
Blood samples were taken within 24 h of patient’s
hospitalization, after 12 h of fasting. Serum samples
were subjected to centrifuge at 3000 rpm for 15 min,
and conserved at -85 °C until the analysis of lipid and
micro-CRP parameters. Analyses of the serum’s total
cholesterol (TC), triglyceride (TG), high-density
lipoprotein (HDL-c), and low-density lipoprotein
(LDL-c) were performed using the Abbot Architect
C16000 autoanalyzer.
LDL-c levels of ≥ 130 mg/dL in non-diabetics, and
≥ 100 mg/dL diabetics were considered as elevated
LDL values (10).
Our hospital is a central hospital in the region.
Patients from other regional hospitals were referred
to our hospital, enabling us to reach a total of 452
subject. Thus, we think that the number of patients
examined in our current study is sufficient for
drawing conclusions.
Statistical analysis
Categorical variables were expressed as
percentages and compared using the chi-square
test or Kruskal-Wallis test. Continuous data were
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presented as means ± standard deviation. One
sample Kolmogorov-Smirnov test was performed to
evaluate normal distribution of continuous variables.
Differences in continuous variables between groups
were determined using Student’s t-test or MannWhitney U test for variables with or without normal
distribution, respectively. Univariate correlations
between 2 continuous variables were analyzed
using Pearson correlation coefficients or Spearman
correlation according to data distribution. Data were
analysed by one-way analysis of variance (ANOVA)
with a post-hoc comparison using the LSD test. A
P value of < 0.05 was considered to be statistically
significant. All analyses were performed using SPSS
v.16.0 (SPSS Inc, USA).
Results
Our study included 452 patients (333 men, 119
women) with a mean age of 63 ± 13 years (Table 1).

Table 1. Distribution of risk factors according to all patients.
All Patients
n = 452 (%)
BMI

28±4.7

Gender, male, n (%)

333 (74)

HT, n (%)

189 (42)

DM, n(%)

95 (21)

Family history, n (%)

199 (44)

Smoking, n (%)

181 (40)

Total-c, mg/dL

185 ± 40

LDL-c, mg/dL

118 ± 33

HDL-c, mg/dL

38 ± 10

Trigliceride#, mg/dL

149 ± 76

High LDL-c¥, n (%)

194 (43)

Total-c/HDL-c

5.1 ± 1.6

Total-c/HDL-c ≥ 4.5, n (%)

282 (62)

Micro CRP#, μg/dL

2.9 ± 6.1

Evaluation of risk factors according to age
groups
The general characteristics of patients according
to age are shown in Table 2. Most of the patients
were in the middle and advanced age groups.
Levels of micro-CRP and the incidence of DM were
similar in all groups. In all age groups, risk factors
were more frequently seen among male patients
and a statistically significant decrease in risk factors
was detected to correlate with aging (P < 0.001).
BMIs differed significantly between Groups 2 and
3 (P < 0.001). A significant increase in the number
of hypertensive patients with age was detected. The
incidence of smoking was highest in Group 1 (71%)
and a statistically significant decrease in smoking
was detected with aging (P < 0.001). Triglyceride
levels were lower in Group 3, and intergroup
difference was statistically significant (P < 0.001).
Although higher LDL-c level was similar in Groups
1 and 2, the difference was statistically significant
between Groups 2 and 3. In addition, the total-c/
HDL-c ratio was significantly different between
Groups 1 and 3 and Groups 2 and 3 (P < 0.001).
The occurrence of a total-c/HDL-c ratio greater
than 4.5 was detected to be higher in Group 1 (P
< 0.05). When all risk factors (age, gender, family
history, HT, DM, smoking, and higher LDL) were
considered, at least one risk factor was detected in
97% of the patients.
Evaluation of risk factors according to gender
Smoking was more frequently seen in male
patients (P < 0.001). Hypertension, HDL-c levels,
and total-c/HDL-c ratios were higher in females (P
< 0.001, P < 0.01, and P < 0.05, respectively). Other
risk factors appeared to be similar in both genders
(Table 3).
Evaluation of risk factors on the basis of ECG
findings
The prevalence of smoking was significantly
higher in male and female subjects in Group 1 as
compared to Groups 2 and 3 (P < 0.002). Age and
micro-CRP levels were statistically significant (P <
0.05) (Table 4).
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Table 2. Distribution of risk factors according to age groups.
Group 1
n = 34 (%)

Group 2
n = 204 (%)

Group 3
n = 214 (%)

BMI

28 ± 3.9

29 ± 4.6

27 ± 4.8c***

Gender, male, n (%)

32 (94)

175 (86)

126 (59)b***c***

HT, n (%)

4 (12)

75 (37)a**

110 (51)b*** c**

DM, n(%)

6 (18)

21 (43)

46 (22)

Family history, n (%)

19 (56)

98 (48)

82 (38)b*c*

Smoking, n (%)

24 (71)

110 (54)

47 (22)b***c***

Total-c, mg/dL

194 ± 38

190 ± 38

179 ± 42b*c**

LDL-c, mg/dL

125 ± 35

120 ± 31

114 ± 34b*c*

HDL-c, mg/dL

35 ± 5.6

37 ± 9

39 ± 10.7b**c*

Trigliceride , mg/dL

180 ± 89

165 ± 83

129 ± 61b***c***

High LDL-c¥, n (%)

16 (47)

102 (50)

77 (36)b*c**

5.69 ± 1.31

5.42 ± 1.89

4.74 ± 1.24b***c***

27 (79)

137 (67)

118 (55)b**c*

3.04 ± 4.63

2.30 ± 3.67

3.44 ± 7.86

Parameters

#

Total-c/HDL-c
Total-c/HDL-c ≥ 4.5, n (%)
Micro CRP#, μg/dL

Data were analyzed by one-way analysis of variance (ANOVA) with a post-hoc comparison using the LSD test.
Comparison of patients with Group 1 vs. Group 2, (a) Group 1 vs. Group 3 (b) and Group 2 vs. Group 3 (c)
#
Sign shows the parameter with nonparametric distribution; * 0.0 5 > P, ** 0.005 > P and *** 0.001 > P
¥
High LDL-c indicates the sum of LDL-c ≥ 100 mg/dL for diabetic patients and LDL-c ≥ 130 mg/dL for non-diabetic
patients

Table 3. Distribution of risk factors according to gender.
Male
n = 333 (%)

Female
n = 119 (%)

BMI

28 ± 4.1

29 ± 6.0

0.062

Age, year

63 ± 13

62 ± 13

0.350

HT, n (%)

123 (37)

66 (55)

0.001

DM, n (%)

73 (22)

22 (19)

0.430

Family history, n (%)

150 (45)

49 (41)

0.466

Parameters

Smoking, n (%)

170 (51)

11 (9)

0.001

Total-c, mg/dL

184 ± 40

187 ± 42

0.435

LDL-c, mg/dL

117 ± 32

119 ± 33

0.556

HDL-c, mg/dL

37 ± 9.4

40 ± 10.3

0.001

Trigliceride , mg/dL

153 ± 82

139 ± 58

0.091

High LDL-c¥, n(%)

146 (44)

48 (40)

0.507

4.86 ± 1.23

5.22 ± 1.72

0.050

214 (64)

68 (57)

0.169

2.53 ± 3.97

3.92 ± 9.81

0.330

#

Total-c/HDL-c
Total-c/HDL-c ≥ 4.5, n(%)
Micro CRP#, μg/dL
¥

P

High LDL-c indicates the sum of LDL-c ≥ 100 mg/dL for diabetic patients and LDL-c ≥ 130 mg/dL for non-diabetic
patients.
#
Sign shows the parameter with nonparametric distribution
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Table 4. Distribution of risk factors according to ECG findings.
Group 1
n = 156 (%)

Group 2
n = 78 (%)

Group 3
n = 218 (%)

Age, year

61 ± 14

65 ± 12a*

63 ± 12

BMI

27 ± 4.1

27 ± 5.8

28 ± 4.6b*

Gender, male, n (%)

126 (81)

46 (59)a***

161 (74)b** c*

HT, n (%)

70 (45)

32 (41)

87 (40)

DM, n(%)

28 (18)

15 (19)

52 (24)

Family history, n (%)

60 (39)

32 (41)

107 (49)

Smoking, n (%)

81 (52)

19 (25)a***

81 (37)b*** c*

Total-c, mg/dL

185 ± 42

187 ± 45

184 ± 38

LDL-c, mg/dL

117 ± 32

120 ± 36

117 ± 33

HDL-c, mg/dL

38 ± 8.4

39 ± 10.4

38 ± 10.5

Trigliceride#, mg/dL

149 ± 87

134 ± 58

154 ± 74

High LDL-c¥, n (%)

72 (46)

38 (44)

88 (40)

5.16 ± 1.98

5.01 ± 1.46

5.14 ± 1.35

90 (58)

49 (63)

143 (66)

3.2 ± 4.8

4.3 ± 11.3

2.2 ± 3.8b*

Parameters

Total-c/HDL-c
Total-c/HDL-c ≥ 4.5, n (%)
#

Micro CRP , μg/dL

Data were analyzed by one-way analysis of variance (ANOVA) with a post-hoc comparison using the LSD test.
Comparison of patients with Group 1 vs. Group 2 (a), Group 1 vs. Group 3 (b), and Group 2 vs. Group 3 (c)
#
Sign shows the parameter with nonparametric distribution; * 0.0 5 > P, ** 0.005 > P and *** 0.0001 > P
¥
High LDL-c indicates the sum of LDL-c ≥ 100 mg/dL for diabetic patients and LDL-c ≥ 130 mg/dL for non-diabetic
patients.

Discussion
From the perspective of preventive medicine,
in addition to the recognition of modifiable and
non-modifiable risk factors that influence CAD,
consideration of regional differences is of crucial
importance. The aim of this study was to determine
the distribution pattern of well-known cardiovascular
risk factors in our region in order to contribute to
the development of primary and secondary regional
prophylactic strategies for CAD.
Cases of coronary and atherosclerotic vascular
diseases constitute the group at highest risk for
mortality and morbidity. The purpose of primary and
secondary prophylaxis in these cases is to decrease
morbidity and mortality while increasing the
patient’s quality of life, and life expectancy (11). The
effectiveness of secondary prophylaxis in patients
with CAD correlates directly with a recognition of
the risk factors in affected individuals.

Our study is the first investigation analyzing
coronary artery risk factors in our region for different
subtypes of CAD based on electrocardiographic data.
The results of this study show that in the younger
age group, the most frequently encountered risk
factors were smoking, family history positivity, and
a total-c/HDL-c ratio of ≥ 4.5, while in the advanced
age group DM and HT were the most frequently
detected risk factors. In addition, higher LDL-c
values were detected in the younger age group. When
all risk factors were considered, another important
outcome of this study was that 97% of the patients
had at least one modifiable risk factor. In a similar
subgroup analysis of the study performed by Khot
et al. in Cleveland clinics, 85% of the patients had at
least one risk factor (12).
Advanced age is an important non-modifiable
risk factor for CAD, which is the most frequently
encountered fatal disease both in men and women
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aged ≥ 65 years (13). In our study, 47% of our patients
aged ≥ 65 years, and only 8% of our cases aged ≤ 44
years. In ECG subgroup analyses, the group with STelevation was younger than that with ST-depression
with a significant difference in terms of the presence
of risk factors. In our study, HT is revealed as an
important influential risk factor for morbidity and
mortality, with an incidence increasing with age.
In studies performed, differences have been
demonstrated between male and female patients
with regard to the frequency of CAD, its clinical
outcomes, and associated risk factors. CAD was seen
2-5 times more frequently in men. Furthermore,
important differences in the prevalence of modifiable
risk factors between genders have been revealed
(14). In our study, 74% of our patients were male, a
group which constituted a higher percentage (81%)
of patients with STEMI, and 59% of cases with ST
depression (P < 0.001). Some authors have reported
higher percentages of modifiable risk factors in
men. Others have indicated that risk factors such as
DM and HT were the most important predisposing
factors for the development of CAD in men while
acute myocardial infarction held this position for
women (15). In our study, HT, HDL-c, and Total-c/
HDL-c were more frequently seen in women (P <
0.001), while smoking was more prevalent among
male patients. No other significant differences in risk
factors were detected.
Although
preliminary
studies
reported
controversial data concerning the family histories
of the patients, more recent investigations have
determined them to be an important risk factor
especially for males and those female patients aged
< 60 years (16). In accordance with the results of our
study, the INTERHEART study also demonstrated
family history positivity to be a more important risk
factor in younger age group (P < 0.05) (2).
It was shown that with modification of modifiable
risk factors in patients with coronary artery disease,
the incidence of non-fatal coronary events could be
reduced, and the number of fatal CVS cases could be
halved (17). Despite the abundance of scientific data,
however, the incidence of smoking, HT, and, most
especially, dyslipidemia rank at higher levels than
anticipated, particularly in developed countries (18).
This phenomenon is attributed partly to the inability
322

of physicians to follow-up with their patients properly
and the insufficient compliance of patients to the
recommendations of their physician (19).
In Turkey, the TEKHARF study, which was
performed in order to detect the prevalence of
heart disease and associated risk factors in the adult
population, has provided us with very important
information (20,21). As a result of the study, DM, HT,
smoking, and elevated LDL levels were accepted as
the most important parameters among well-known
modifiable risk factors contributing to the increased
risk of CAD.
Especially in women, the incidence of acute
myocardial infarction increases in the presence of DM
and HT. In the INTERHEART study, the frequency
of DM was determined to be 26% in women and 16%
in men (2). The incidence of DM in patients with
CAD as documented angiographically by Sönmez
et al. was found to be 31% in women and 18% in
men, while Aygül et al. detected corresponding rates
in patients with AMI as 38% and 16%, respectively
(22,23). In our study, the frequency of DM in male
and female patients was determined to be 19% and
22%, respectively.
The incidence of hypertension in our study was
found to be 55% in men and 37% in women, figures
that are similar to the percentages reported for the
INTERHEART study (53%, 35%), and the 2 other
above-mentioned studies (60%, 37% and 65%, 28%)
(25,26). In the INTERHEART study, HT and DM
were reported to be highly influential risk factors,
ranking just behind smoking and apolipoprotein B/
apolipoprotein A1 ratio (2).
As demonstrated in the MRFIT (Multiple Risk
Factor Intervention Trial) study, a strong correlation
was found between total cholesterol and CAD, which
was more prominent in patients with total cholesterol
values above 200 mg/dL (24). When compared with
European countries, the TEKHARF study revealed a
higher incidence of coronary morbidity and mortality
with lower levels of total and LDL cholesterol in the
overall Turkish population. This phenomenon was
attributed to the lower levels of HDL cholesterol
found in the Turkish population (5,7,25). In the
Turkish Heart Study, total and LDL cholesterol values
were found to be different in 6 discrete regions which
were categorized according to dietary habits while
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HDL cholesterol levels were detected to be lower in
all regions, independent of dietary habits (26). In the
cited study, HDL-c levels in male subjects ranged
between 34 and 38 mg/dL, which were 10 mg/dL
lower than the national average when compared with
our American and European counterparts. Similar
findings were detected in Turks living in Europe
and the USA and genetic factors became prominent
because of higher hepatic lipase activity found in the
Turkish population (27). In our study, mean HDL
cholesterol level was determined to be 37 ± 9.4 mg/
dL in men and 40 ± 10.3 mg/dL in women, a finding
which is consistent with the data from the TEKHARF
study.

in Turkey and one that is increasingly prevalent.
In this country, smoking has been shown to be the
most frequently encountered risk factor, especially
in the younger age group. In the TEKHARF study,
the incidence of smoking was 43% and 18% in men
and women, respectively, while the corresponding
percentages in our own study were found to be 45%
and 41% (30). In the younger age group, an even
higher rate (71%) was detected. The INTERHEART
study also demonstrated that smoking increased the
incidence of non-fatal myocardial infarction 3-fold,
a figure which increased linearly with the number of
cigarettes smoked (2).

Higher LDL-cholesterol levels were detected
in 45% of the patients, which paralleled with the
data previously attained. The total-c/HDL-c ratio
which has been used for the evaluation of CAD
risk in patients with normal LDL cholesterol levels
is a parameter dependent upon variations in HDL
cholesterol levels. In a study conducted by Onat et al.
in the Turkish population, the mean total-c/HDL-c
ratio was found to be 5.18 in men and 4.25 in women,
while the corresponding values were detected to be
5.17, and 5.05 in the presence of CAD (28). In the
Turkish Heart Study, the mean total-c/HDL-c ratio
was detected to be 5.4 in men and 3.9 in women
(29); in our study, however, the corresponding
values were 4.86 ± 1.23 and 5.22 ± 1.72, respectively.
This discrepancy is thought to originate from
significant gender differences with regard to HDL-c
concentrations (P < 0.001).

The lack of any control group constituted the main
limitation of our study. We chose not to use a control
group, however, since the aim of our investigation
was to determine regional distribution of traditional
risk factors.

In the etiopathogenesis of acute coronary
syndrome, smoking is revealed as the most important
modifiable risk factor in both male and female
patients. Tobacco use is a serious health problem

Study limitations

Conclusions
This investigation is the first epidemiological
study performed with the intention of evaluating the
distribution of conventional risk factors in patients
hospitalized with the diagnosis of CAD in the
eastern Black Sea region. At least one risk factor was
detected in 97% of our patients. More specifically,
in the younger age group, family history positivity,
tobacco use, hypercholesterolemia, decreased HDL,
and lower total-c/HDL-c ratios were more prevalent,
while lower values for HT and HDL-c levels were
detected in the same age group. These findings have
demonstrated the crucial role of modification of risk
factors in the avoidance and prevention of CAD,
especially in the younger age group.
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